glp 1 insulin combo GLP-1 Agonists: Increasing Effective Release Is Toujeo a GLP-1? The
Description
genetics, hormones, activity, environment, socio-economic status all play a role in obesity
Estimated hazard ratio for 6 mg/weekly dose of efpeglenatide compared to placebo was 0,65 (95% CI, 0.5 to 0.86) and 0.82 (95% CI 0.63 1.06) for 4 mg/weekly dose compared to placebo (44)
Clinicians should also be cautious in the case of T2D patients receiving drugs that inhibit the renin-angiotensin system
These compounds, particularly antioxidants like anthocyanins , flavonoids , and vitamin C , play a role in improving insulin sensitivity, reducing inflammation, and supporting glucose metabolism
